Hemogenyx's innovative and revolutionary products can keep investors' eyes on the company.
Hemogenyx Pharmaceuticals Ltd. will start trading on the London Stock Exchange under the ticker symbol HEMO on Thursday, October 5, 2017.
Innovations in the industry are enticing investors to buy biotech stocks.